Celia Oreja-Guevara (Vice Chair of Neurology and Head of Multiple Sclerosis Center, University Hospital San Carlos, and Professor of Neurology, University Complutense, Madrid, Spain) discusses the background and findings of her presentation entitled: Patient involvement in treatment decision-making: a sub-analysis of the ‘MS in the 21st Century international unmet needs survey’ comparing patient and healthcare professional perspectives.
Questions
1. What is the ‘MS in the 21st Century’ initiative? (0:12)
2. What was the objective of the sub analysis that you’re presenting here at EAN? How were the data collected? (1:06)
3. What did the data reveal about approaches to treatment discussions and the factors that influence treatment decisions? (2:30)
4. What impact do you hope these findings will have on treatment decision-making in the future? (4:03)
Speaker disclosure: Celia Oreja-Guevara has nothing to disclose in relation to this video interview.
‘MS in the 21st Century’ is a Merck KGaA, Darmstadt, Germany initiative involving healthcare professionals and patient advocates
Filmed at the 4th Congress of the European Academy of Neurology (EAN), Lisbon, Portugal, June 2018.
